Siqi Liu Selected Research

jianpi yishen

1/2022

A Chinese Medicine Compound Alleviates Cisplatin-Induced Acute Kidney Injury via Its Antiapoptosis and Anti-Inflammation Effects in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siqi Liu Research Topics

Disease

37	Neoplasms (Cancer) 07/2022 - 08/2007
13	Inflammation (Inflammations) 01/2022 - 07/2007
11	Carcinogenesis 01/2022 - 03/2007
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2008
7	Stomach Neoplasms (Stomach Cancer) 07/2022 - 06/2006
7	Fatty Liver 01/2022 - 01/2019
5	Fibrosis (Cirrhosis) 01/2021 - 04/2018
5	Liver Neoplasms (Liver Cancer) 12/2015 - 08/2013
4	COVID-19 01/2022 - 01/2021
4	Chronic Renal Insufficiency 01/2022 - 01/2020
4	Severe Acute Respiratory Syndrome 12/2003 - 08/2003
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2019
3	Carcinoma (Carcinomatosis) 01/2022 - 01/2013
3	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2019
3	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2021
3	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2017
3	Infections 09/2017 - 12/2007
3	Esophageal Squamous Cell Carcinoma 04/2016 - 09/2015
3	Neoplasm Metastasis (Metastasis) 09/2014 - 08/2008
2	Epilepsy (Aura) 07/2022 - 01/2022
2	Ascites 07/2022 - 11/2012
2	Ventricular Fibrillation 01/2022 - 10/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 03/2015
2	Liver Diseases (Liver Disease) 01/2022 - 01/2010
2	Aneuploidy (Aneuploid) 12/2021 - 11/2016
2	Hepatitis B 11/2021 - 01/2021
2	Chronic Hepatitis B 11/2021 - 01/2019
2	Tuberculosis (Tuberculoses) 01/2021 - 01/2020
2	Insulin Resistance 01/2021 - 01/2017
2	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 10/2020 - 10/2017
2	Atherosclerosis 08/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2013
2	Necrosis 01/2020 - 01/2014
2	Bites and Stings (Sting) 01/2019 - 03/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 08/2013
2	Lung Neoplasms (Lung Cancer) 01/2013 - 03/2007
2	Pathologic Processes 01/2013 - 01/2011
1	Hemorrhage 12/2022
1	Autism Spectrum Disorder 07/2022

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
7	ProteomeIBA 01/2022 - 01/2013
7	LipidsIBA 10/2021 - 01/2017
7	Messenger RNA (mRNA)IBA 01/2021 - 01/2014
6	InterleukinsIBA 07/2022 - 09/2017
6	Biological ProductsIBA 06/2022 - 11/2007
6	Peptides (Polypeptides)IBA 01/2022 - 01/2020
6	CytokinesIBA 01/2021 - 10/2016
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2013
5	AntibodiesIBA 01/2022 - 01/2020
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2014
5	Indicators and Reagents (Reagents)IBA 01/2019 - 08/2007
3	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 10/2020
3	EnzymesIBA 01/2022 - 04/2016
3	VaccinesIBA 01/2022 - 08/2003
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 07/2021 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
3	AntigensIBA 01/2020 - 01/2013
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2017 - 01/2016
3	AzoxymethaneIBA 12/2017 - 01/2016
3	Dextrans (Dextran)FDA Link 12/2017 - 01/2016
3	Antiviral Agents (Antivirals)IBA 09/2017 - 12/2003
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2014
3	Cathepsin DIBA 01/2017 - 03/2007
3	Aldo-Keto ReductasesIBA 04/2016 - 05/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
2	ImmunosorbentsIBA 01/2022 - 08/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2020
2	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 12/2021 - 01/2013
2	Amino Acids FDA Link 11/2021 - 01/2020
2	Betaine (C.B.B.)FDA Link 10/2021 - 01/2019
2	LycopeneIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 01/2021 - 11/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
2	NAD (NADH)IBA 01/2021 - 01/2021
2	Thrombin FDA Link 12/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2016
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2020 - 01/2020
2	AutoantibodiesIBA 01/2020 - 01/2013
2	Protein Isoforms (Isoforms)IBA 10/2017 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 10/2016 - 01/2016
2	Interferon Type IIBA 03/2015 - 08/2013
2	Phosphotransferases (Kinase)IBA 03/2015 - 09/2014
2	Tumor Biomarkers (Tumor Markers)IBA 08/2014 - 08/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2022
1	Adenosine (Adenocard)FDA LinkGeneric 07/2022

Therapy/Procedure

17	Therapeutics 07/2022 - 07/2007
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2020
2	Lasers (Laser) 01/2022 - 01/2021
2	Cardiopulmonary Resuscitation (CPR) 01/2022 - 10/2021
2	Immunotherapy 01/2022 - 01/2016
1	Ligation 12/2022